The present study was performed to design oral controlled delivery systems for the water-soluble drug, verapamil hydrochloride, using natural and semisynthetic polymers as carriers in the forms of 1-and 3-layer matrix tablets. Verapamil hydrochloride 1-layer matrix tablets containing hydroxypropylmethylcellulose, tragacanth, and acacia either alone or mixed were prepared by direct compression technique. 3-layer matrix tablets were prepared by compressing the polymers as release retardant layers on both sides of the core containing the drug. The prepared tablets were subjected to in vitro drug release studies. Tragacanth when used as the carrier in the formulation of 1-and 3-layer matrices produced satisfactory release prolongation either alone or in combination with the other 2 polymers. On the other hand, acacia did not show enough prolonging efficiency in 1-and 3-layer matrix tablets. The results also showed that the location of the polymers in the 3-layer tablets has a pronounced effect on the drug release. Kinetic analysis of drug release from matrices exhibiting sustained release indicated that release was predominantly attributable to the contribution made by Fickian diffusion, while the erosion/relaxation mechanisms had a minor role in the release.
INTRODUCTION
Developing oral controlled release tablets for highly watersoluble drugs with controlled release rate has always been a challenge to the pharmaceutical technologist. Most of these highly water-soluble drugs, if not formulated properly, may readily release the drug at faster rate than desired and are likely to produce toxic concentrations, on oral administration. Hence, it is a challenging task to formulate a suitable tablet dosage form for prolonged delivery of highly watersoluble drugs.
Diffusion-controlled polymeric matrix devices have been widely used as drug delivery systems mainly owing to their low manufacturing cost. 1 Generally, in conventional diffusion-controlled matrix systems, in which the drug to be released is uniformly dispersed throughout the polymer, the release inherently follows first-order diffusion with an initially high release rate followed by a rapidly declining rate. To overcome this undesired behavior, various matrix geometries have been employed over the last 2 decades resulting in almost constant release of the drug with time. 2, 3 A proper technique relies on the use of multi-layer matrix devices where the matrix core, containing the drug or any other active solute, is covered by one or more modulating layers that act as rate-controlling barriers. [4] [5] [6] In this research, verapamil hydrochloride was chosen as model drug. Because of high solubility, short half-life, and therapeutic use of verapamil in chronic diseases, it was considered an ideal drug candidate for the design of oral controlled release dosage forms. Different polymers have been employed for sustaining the drug delivery. In the present investigation, we have used tragacanth, acacia, and hydroxypropylmethylcellulose (HPMC) as release retardant carriers in the design of 1-and 3-layer matrix tablets.
Tragacanth is a naturally occurring dried gum obtained from Astragalus gummifer Labillardiere and other species of Astragalus grown in western Asia. The gum consists of a mixture of water-insoluble and water-soluble polysaccharides. Bassorin, which constitutes 60% to 70% of the gum, is the main water-insoluble portion, while the remainder of the gum consists of the water-soluble material, tragacanthin. Tragacanth gum is used as an emulsifying and suspending agent in a variety of pharmaceutical formulations. It is used in creams, gels, and emulsions at various concentrations according to the application of the formulation and the grade of gum used.
Acacia is a complex, loose aggregate of sugars and hemicelluloses with a molecular weight of~240 000 to 580 000. Acacia is mainly used in oral and topical pharmaceutical formulations as a suspending and emulsifying agent, often in combination with tragacanth. It is also used in the preparation of pastilles and lozenges, and as tablet binder.
The purpose of the present study was to evaluate the potency of tragacanth and acacia to sustain the release of a water-soluble drug, verapamil hydrochloride, and the effect of the geometry and design of the 3-layer tablet on drug release.
MATERIALS AND METHODS
Verapamil hydrochloride was obtained from Sobhan Pharmaceuticals (Rasht, Iran). Tragacanth, acacia, and magnesium stearate were purchased from Merck (Darmstadt, Germany). HPMC K15M was kindly provided as gift by Colorcon (Dartford Kent, UK).
Preparation of Verapamil Hydrochloride 1-Layer Matrix Tablets
One-layer matrix tablets containing 120 mg of verapamil hydrochloride were prepared by direct compression method. The composition of each tablet is shown in Table 1 . All the components of each formulation except magnesium stearate were thoroughly mixed in a bottle using tumbling method for a period of 15 minutes. Magnesium stearate was added to the formulations at the end of mixing period and mixed for 2 more minutes. Tablets were directly compressed on a hydraulic press (Riken, Japan) using flatfaced 8-mm-diameter punch and die set at a pressure of 4.5 to 6.9 MPa to have a crushing strength of 5 to 6 Strong Cobb (equivalent to 37-41.2 N according to technical brochure of the hardness tester, Erweka, Heusenstamm, Germany). Tablets were kept in tightly closed containers for further studies.
Preparation of 3-layer Matrix Tablets
3-layer matrix tablets were prepared by compressing different amounts of polymers on both sides of tablet containing 120 mg verapamil hydrochloride by means of the same compressor used to compress the 1-layer tablets. A preweighed amount of polymer as the bottom layer was taken and placed in die cavity and slightly compressed for uniform spreading. The upper punch was lifted and powders of the matrix core formulation were placed over the bottom layer in the die cavity and again slightly compressed for uniform spreading. The remaining volume of the die cavity was filled with the preweighed amount of polymer as the top layer and compressed with a 6.9 MPa pressure to obtain 3-layer matrix tablets. The top and bottom layers of the 3-layer matrix tablet acted as releaseretardant polymer layers. Table 2 indicates the composition and polymer locations of different layers.
Drug Release Studies
Drug release studies were performed using United States Pharmacopeia (USP) 26 apparatus Ι (basket), (Erweka, Heusenstamm, Germany). The dissolution medium was 900 mL of distilled water maintained at 37°C ± 0.5°C. The basket rotation speed was kept at 100 rpm. In all experiments, an aliquot of 5 mL sample was withdrawn at predetermined time intervals and replaced with an equal volume of the fresh medium to maintain the total volume constant. The samples were assayed using UV spectrophotometer at 278.4 nm. Cumulative percentage of drug released from the tablets was calculated and plotted as a function of time. Each formulation was tested in triplicate and a mean of 3 measurements was reported.
Analysis of Drug Release Data
For the evaluation and comparison of the release profiles, dissolution efficiency (DE) as a model independent criterion was used. 8 DE can be calculated according to Equation 1:
in which the integral represents the area under the dissolution curve between times zero and T; y is the percentage drug released up to time t and y 100 indicates 100% release. T in our study was 480 minutes.
In order to establish the kinetic mechanisms of drug release from matrices exhibiting sustained release, the data were fitted to a 2-term power law (Equation 2) 9 using the SPSS package Version 11.5.0 (SPSS Inc, Chicago, IL): -F2  120  -120  -F3  120  -160  -F4  120  -200  -F9  120  -80  80  F10  120  160  --F11  120  200  --F12  120  240  --F13  120  280  --F24  120 where Q denotes the fraction of drug released in time t, (Q ≤ 60%); M t and M∞ are the amounts of drug released at time t and the overall amount released, respectively; K 1 and K 2 represent kinetic constants associated with diffusional and relaxational release, respectively; and m is the purely Fickian diffusion exponent. Depending on the aspect ratio of the device, m varies between 0.42 and 0.5. The diffusional/erosional contribution can be obtained by comparison of the diffusional and relaxational constants obtained from Equation 2.
RESULTS AND DISCUSSION
Drug Release Studies on Acacia 1-and 3-Layer Tablets Figure 1 shows the release profiles of the drug from 1-layer matrices prepared of acacia. It can be seen from the figure that the release of the drug from the matrices was fast and the increase in the amount of acacia from 80 to 200 mg did not affect the release rate significantly.
Acacia 3-layer tablets have been designed to evaluate the effect of geometry and design of tablet on drug release profile. Formulation F3 with 160 mg acacia has been selected and 2 different 3-layer formulations have been prepared (F5, F6) . The release of drug from 3-layer tablets of acacia is shown in Figure 2 . Similar to 1-layer matrices, the release was rapid. This result can be because the acacia chains are short, and their hydration is too fast, together with low viscosity and rapid diffusion of drug molecule from loose acacia gel, 10, 11 which results in rapid disintegration and dissolution. Also the drug release from these matrices does not appear to be geometry and design dependent. An important point that should be considered is that in none of the acacia-containing formulations has verapamil release reached 100%. This phenomenon can be related to the interaction between the cationic verapamil and anionic acacia. 12 Because of fast release rates of drug from 1-and 3-layer formulations of acacia, Equations 1 and 2 were not applied to their corresponding data.
Drug Release Studies on 1-and 3-layer Tablets Containing Acacia-HPMC Acacia did not show enough prolonging effect when it was incorporated as the only polymer into the tablets, either in 1-or 3-layer forms. Therefore, HPMC K15M was incorporated into the formulations to evaluate the effect of the tablet design and the location of polymer in either core or outer layers in 3-layer tablets. Figure 3 shows the drug release from 1-and 3-layer formulations containing acacia Acacia  HPMC  K15M  Tragacanth  Acacia  HPMC  K15M   F5  120  -80  --40  -F6  120  -40  --60  -F7  120  -80  ---40  F8  120  --80  -40  -F14  120  160  --40  --F15  120  140  --50  --F16  120  100  --70  --F17  120  80  --80  --F18  120 and HPMC (F7-F9). Verapamil has been released with a faster rate from F7, in which acacia was located in the core of the matrix. This phenomenon can be related to the above mentioned properties of acacia. Acacia in comparison with HPMC forms a gel with lower viscosity and higher permeability. Drug can easily diffuse out of the gel formed by acacia, but the HPMC gel has greater rigidity; then there is a barrier for penetration of dissolution medium into HPMC gel and diffusion of drug out of that. It can be seen from the results of formulations F7-F9 that when a polymer with higher capability to form a more viscous gel either is placed in the core of the 3-layer tablet (F8) or incorporated in 1-layer (F9), the drug release slows down. Figure 4 shows the drug release from 1-layer tragacanth matrices containing different amounts of the gum (F10-F13). The higher the amount of the gum, the more efficient is prolongation. Formulation F10, which has less tragacanth content, shows a higher drug release rate (DE 480 = 63.01) than formulations F11-F13 (DE 480 = 54.48-53.49).
However the release did not differ from the latter 3 despite having increased amounts of the gum contents. Similar to acacia, tragacanth, owing to its anionic nature, prevents 100% release of the cationic verapamil from the matrices. 13 Comparing the DE 480 values of 1-layer tragacanth matrices with those of 1-and 3-layer acacia matrices indicates the superiority of the prolongation effect of tragacanth with respect to acacia. The prolongation efficiency of tragacanth was also demonstrated for chlorpheniramine tablets by other workers.
14,15
The release profiles of 3-layer tragacanth matrices containing equal amounts of gum but with different geometry and design (F14-F19) are shown in Figure 5 . The figure shows that when the drug alone was located in the core (F19), the fastest release (DE 480 = 60.9) was achieved, accompanying the burst release during the early time. This result is because the drug is in direct contact with dissolution medium from the peripheral side of the tablet. The slowest release was seen with F14 and F15, where the gum content was maximum in the core (DE 480 = 48.21, 49.55). This result is because of the highest polymer/drug ratio in the core of these formulations. However, the amount of drug released in 480 minutes from formulations was approximately the same. Therefore it can be concluded that the geometry and design of the tablet can mostly affect the rate of release not the overall amount of drug released in 8 hours.
Drug Release Studies on Tragacanth-HPMC 3-Layer Tablets Figure 6 shows the release profiles of 3-layer matrices containing tragacanth in outer layers and HPMC in the core, but with different amounts. Formulation F20, which had a higher amount of HPMC in the core, showed slower drug release (DE 480 = 33.65) as compared with F21 (DE 480 = 37.98). These results indicate the efficiency of HPMC for prolonging the drug release. Increased amount of tragacanth in layers of formulation F21 did not compensate for the decreased amount of HPMC in core, compared with formulation F20. Figure 7 shows the release profiles of 3-layer matrices with outer layers of HPMC and the core consisting of tragacanth (F22), with outer layers of tragacanth and the core of HPMC (F23), and with a 1-layer matrix containing total amount of both polymers equal to the previous ones (F24 In the first 4 hours, the drug has been released from F23 at a slower rate, but after this time there is no pronounced difference between the release profiles of drug from these 3 formulations (F21-F23). The total amount of drug released after 480 minutes is nearly the same for these formulations. It can be concluded that HPMC can greatly control the release of drug in the first hour when it is incorporated in the core of the 3-layer matrix tablet; this may advantageous in preventing the side effects of drug if such effects are induced by rapid drug release. Drug Release Studies on Tragacanth-Acacia 3-Layer Tablets Figure 8 shows the release curves of drug from 3-layer matrices with the outer layers of tragacanth and the core of acacia (F25), and acacia in the outer layers with the core of tragacanth (F26). As was predicted, since a polymer with the capability of producing a higher gel strength, tragacanth, was located in the core, (F26) exhibited a pronounced slower drug release (DE 480 = 78.61) than F25, which contained acacia in the core (DE 480 = 91.12).
Evaluation of the Release Kinetics
Drug release from swellable water-soluble polymer systems is typically described in terms of 2 simultaneously operating mechanisms. These are Fickian diffusion through the hydrated outer layers of the matrix and matrix relaxation/ erosion. 16, 17 The contributions of these 2 mechanisms to the overall release are considered additive. A well-known empirical model that describes these phenomena is that of Peppas and Sahlin (Equation 2). 9 The model was applied to formulations F10-F24, which demonstrated sustained release properties. The results of the analysis are shown in Table 4 . Considering the values for K 1 , K 2 , and K 2 /K 1 , it is clear that for these formulations, overall release is predominantly attributable to the contribution made by Fickian diffusion with a minimal contribution offered by matrix erosion/relaxation. 18, 19 However, the extent of the Fickian diffusion contribution to the overall release is vastly different among the formulations. It is maximum in the case of F10 and minimum for F23. Moreover, the ratio of erosion constants to that of diffusion is also very different, indicating that the integrity of matrices during the release process was variable. The matrix with higher K 1 value retained its integrity for a longer time.
CONCLUSION
The results of our study show that the polymers possessing higher gelling ability (ie, tragacanth and HPMC) have the potential for sustaining and/or controlling the release of water soluble drug, verapamil hydrochloride, whereas a polymer with a weaker gel forming ability (ie, acacia) lacks such a potential. Also the geometry and design of the matrices has a pronounced effect on slowing the drug release during the first hours, though in most cases the total amount of drug release is not changed considerably. Kinetic analysis shows that the release is predominantly attributable to the contribution made by Fickian diffusion with a minimal contribution made by matrix erosion/relaxation. 
